Clinical descriptions about influenza-like illnesses (ILI) in COVID-19 seem non-specific. We aimed to compare the clinical features of COVID-19 and influenza. We retrospectively investigated the clinical features and outcomes of confirmed cases of COVID-19 and influenza in Nord Franche-Comt e Hospital between February 26th and March 14th 2020. We used SARS-CoV-2 RT-PCR and influenza virus A/B RT-PCR in respiratory samples to confirm the diagnosis. We included 124 patients. The mean age was 59 (±19 [19e98]) years with 69% female. 70 patients with COVID-19 and 54 patients with influenza A/B. Regarding age, sex and comorbidities, no differences were found between the two groups except a lower Charlson index in COVID-19 group (2 [±2.5] vs 3 [±2.4],p ¼ 0.003). Anosmia (53% vs 17%,p < 0.001), dysgeusia (49% vs 20%,p ¼ 0.001), diarrhea (40% vs 20%,p ¼ 0.021), frontal headache (26% vs 9%,p ¼ 0.021) and bilateral cracklings sounds (24% vs 9%,p ¼ 0.034) were statistically more frequent in COVID-19. Sputum production (52% vs 29%,p ¼ 0.010), dyspnea (59% vs 34%,p ¼ 0.007), sore throat (44% vs 20%,p ¼ 0.006), conjunctival hyperhemia (30% vs 4%,p < 0.001), tearing (24% vs 6%,p ¼ 0.004), vomiting (22% vs 3%,p ¼ 0.001) and rhonchi sounds (17% vs 1%,p ¼ 0.002) were more frequent with influenza infection. We described several clinical differences which can help the clinicians during the cocirculation of influenza and SARS-CoV-2.